| Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons MT Islam, F Rumpf, Y Tsuno, S Kodani, T Sakurai, A Matsui, T Maejima, ... Current Biology 32 (18), 3871-3885. e4, 2022 | 11 | 2022 |
| Evaluation of in-office MRI/US fusion transperineal prostate biopsy via free-hand device during routine clinical practice LG Briggs, M Kim, A Gusev, F Rumpf, A Feldman, F McGovern, ... Urology 155, 26-32, 2021 | 9 | 2021 |
| Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy PE Hartrampf, FX Weinzierl, AK Seitz, H Kübler, M Essler, AK Buck, ... the prostate 82 (14), 1406-1412, 2022 | 5 | 2022 |
| CONDITIONAL SURVIVAL IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER H Bendre, F Rumpf, A Gusev, M Wszolek, D Dahl, M Blute, AS Feldman, ... Urologic Oncology: Seminars and Original Investigations 42, S97, 2024 | | 2024 |
| Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer F Rumpf, A Plym, JB Vaselkiv, KL Penney, MA Preston, AS Kibel, ... Journal of Urology, 10.1097, 2024 | | 2024 |
| Detecting clinically significant prostate cancers: Tissue metabolomics refines multiparametric MRI-ultrasound fusion prostate biopsy LL Cheng, AS Feldman, LA Vandergrift, IH Muti, F Rumpf, A Gusev, ... Cancer Research 82 (12_Supplement), 2222-2222, 2022 | | 2022 |
| MP43-10 IMPACT OF FAMILY HISTORY AND GERMLINE GENETIC RISK VARIANTS ON LONG-TERM OUTCOMES OF ACTIVE SURVEILLANCE-ELIGIBLE PROSTATE CANCER F Rumpf, A Plym, J Vaselkiv, M Preston, A Kibel, L Mucci, K Salari The Journal of Urology 207 (Supplement 5), e744, 2022 | | 2022 |
| PD17-08 IMPACT OF SERIAL PROSTATE MULTIPARAMETRIC MRI ON TREATMENT FREE SURVIVAL IN MEN ON ACTIVE SURVEILLANCE J Harvey, A Gusev, J Twum-Ampofo, A Pieretti, F Rumpf, A Yu, K Salari, ... Journal of Urology 206 (Supplement 3), e287-e288, 2021 | | 2021 |
| MP62-12 CONDITIONAL FREEDOM FROM PROGRESSION ON ACTIVE SURVEILLANCE OF PROSTATE CANCER STRATIFIED BY NCCN RISK J Harvey, A Gusev, F Rumpf, K Salari, J Twum-Ampofo, M Wszolek, ... Journal of Urology 206 (Supplement 3), e1096-e1097, 2021 | | 2021 |
| Conditional progression-free survival in men on active surveillance for prostate cancer stratified by NCCN risk. A Gusev, F Rumpf, K Salari, J Twum-Ampofo, MF Wszolek, DM Dahl, ... Journal of Clinical Oncology 39 (6_suppl), 222-222, 2021 | | 2021 |
